Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension. Chest. 2016 Nov; 150(5):1059-1068.

View in: PubMed

subject areas

Double-Blind Method
Factor Xa Inhibitors
Female
Humans
Male
Middle Aged
Pulmonary Embolism
Recurrence
Risk Assessment
Risk Factors
Rivaroxaban
Secondary Prevention
Survival Rate
Treatment Outcome
Venous Thromboembolism

authors with profiles

Gary E Raskob